Natixis Advisors
TECH icon

Natixis Advisors’s Bio-Techne TECH Stock Holding History

Natixis Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.9M Buy
818,905
+170,871
+26% +$9.23M 0.07% 267
2026
Q1 		$33.9M Sell
648,034
-105,246
-14% -$6.32M 0.05% 368
2025
Q4 		$44.3M Buy
753,280
+611,892
+433% +$37.2M 0.06% 280
2025
Q3 		$7.87M Buy
141,388
+43,057
+44% +$2.31M 0.01% 725
2025
Q2 		$5.06M Sell
98,331
-26,586
-21% -$1.34M 0.01% 817
2025
Q1 		$7.32M Sell
124,917
-44,764
-26% -$3.03M 0.01% 719
2024
Q4 		$12.2M Buy
169,681
+11,625
+7% +$854K 0.02% 593
2024
Q3 		$12.6M Buy
158,056
+16,328
+12% +$1.23M 0.02% 586
2024
Q2 		$10.2M Sell
141,728
-111,240
-44% -$8.19M 0.02% 600
2024
Q1 		$17.8M Sell
252,968
-31,224
-11% -$2.23M 0.04% 419
2023
Q4 		$21.9M Buy
284,192
+62,632
+28% +$4.13M 0.06% 334
2023
Q3 		$15.1M Sell
221,560
-42,723
-16% -$3.38M 0.05% 392
2023
Q2 		$21.6M Buy
264,283
+30,008
+13% +$2.41M 0.07% 303
2023
Q1 		$17.4M Buy
234,275
+2,129
+0.9% +$164K 0.06% 330
2022
Q4 		$19.2M Buy
232,146
+68,514
+42% +$5.44M 0.07% 302
2022
Q3 		$11.6M Buy
163,632
+5,520
+3% +$477K 0.05% 393
2022
Q2 		$13.7M Buy
158,112
+3,912
+3% +$367K 0.06% 360
2022
Q1 		$16.7M Buy
154,200
+41,768
+37% +$4.31M 0.06% 326
2021
Q4 		$14.5M Buy
112,432
+336
+0.3% +$41.2K 0.06% 361
2021
Q3 		$13.6M Buy
112,096
+2,720
+2% +$331K 0.06% 340
2021
Q2 		$12.3M Sell
109,376
-2,240
-2% -$236K 0.06% 358
2021
Q1 		$10.7M Sell
111,616
-1,944
-2% -$177K 0.06% 370
2020
Q4 		$9.02M Buy
113,560
+21,172
+23% +$1.53M 0.05% 388
2020
Q3 		$5.72M Sell
92,388
-7,656
-8% -$498K 0.04% 478
2020
Q2 		$6.61M Buy
100,044
+48,196
+93% +$2.89M 0.04% 422
2020
Q1 		$2.46M Sell
51,848
-428
-0.8% -$21.4K 0.02% 670
2019
Q4 		$2.87M Buy
52,276
+11,520
+28% +$604K 0.02% 717
2019
Q3 		$1.99M Buy
+40,756
New +$2.04M 0.02% 777

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Natixis Advisors's TECH Position: Q2 2026 in Review

Natixis Advisors increased its Bio-Techne (TECH) stake by 26% in Q2 2026, buying an estimated $9.23M and bringing the position to 818,905 shares worth $57.9M. The position accounts for 0.07% of the portfolio, ranked #267.

Natixis Advisors first reported a position in TECH in Q3 2019 and has held it in 28 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Natixis Advisors held 818,905 shares of Bio-Techne worth $57.9M as of Q2 2026.
  • Natixis Advisors bought 170,871 Bio-Techne shares in Q2 2026, an estimated $9.23M.
  • Bio-Techne made up 0.07% of Natixis Advisors's portfolio in Q2 2026, its #267 holding.
  • Natixis Advisors first reported a position in Bio-Techne in Q3 2019 and has held it in 28 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.